PP
GI

Paloma Partners’s EndoChoice Holdings, Inc. GI Stock Holding History

Paloma Partners’s Portfolio GI Stock Details GI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-32,957
Closed -$161K – 2367
2016
Q2 		$161K Buy
+32,957
New +$157K ﹤0.01% 2007

Other funds holding GI

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Paloma Partners's GI Position: Q3 2016 in Review

Paloma Partners sold out of EndoChoice Holdings, Inc. (GI) in Q3 2016, closing a stake of 32,957 shares — an estimated $161K sold.

Paloma Partners first reported a position in GI in Q2 2016 and held it in 1 quarter. The position peaked at $161K in Q2 2016. 49 funds tracked by Wall St. Rank hold GI as of Q3 2016.

  • Paloma Partners reported no remaining EndoChoice Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • Paloma Partners sold 32,957 EndoChoice Holdings, Inc. shares in Q3 2016, an estimated $161K.
  • Paloma Partners first reported a position in EndoChoice Holdings, Inc. in Q2 2016 and held it in 1 quarter.
  • Paloma Partners's EndoChoice Holdings, Inc. position peaked at $161K in Q2 2016.
  • 49 funds tracked by Wall St. Rank held EndoChoice Holdings, Inc. as of Q3 2016.

Based on Paloma Partners's 13F filing for Q3 2016, filed 14 Nov 2016.